Table 2

Anti-HBV serological markers in different clinical stages of hepatitis C virus related chronic liver disease

CHLCHCCTotal
Anti-HBs positive25.628.135.4* 29.1
Anti-HBc positive43.849.859.4* 49.9
Age (years)
 <6036.3 (160/441)41.8 (46/110)58.9* (56/95)40.6 (262/646)
 ⩾6050.0 (266/532)52.8 (169/320)59.5*(307/516)54.2 (742/1368)
  • Values represent percentages of the total number of patients in each group. Values in parentheses show the actual number of patients (patients with anti-HBc positive/total patients). HBV, hepatitis B virus; CH, chronic hepatitis; LC, liver cirrhosis; HCC, hepatocellular carcinoma; anti-HBs, antibody to hepatitis B surface antigen; anti-HBc, antibody to hepatitis B core antigen. *Significantly higher than LC or CH group (p<0.01).